AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
DOW
ACCE-researched

Dow Inc. Common Stock (DOW) fair value

Basic Materials · Chemicals · NYSE · United States
$32.61+2.51%
Market cap $23.6BNext earnings 2026-10-22Updated Oct 23, 2026
Our verdict
Trades 45% below our fair value
Price
$32.61
Model fair valueConfidence: low
about $59.62
Built from weaker models, sales multiples or analyst targets, so treat it as a rough guide.
Not used by alerts or posts.
Valued as a loss-making company: Sales comps and Analyst consensus.
ACCE opinionDow Inc. Common Stock (DOW)
Fair value (2 models)
Not available
ACCE price target
$33.00
Rating
Not rated
Horizon
12 months
ACCE price target published on 23 Oct 2026, 01:52 CEST; previously $27.00 since 25 Sept 2026, 00:00 CEST.
Price used: $32.61 at the close on 23 Oct 2026, 22:00 CEST.
Models: Analyst consensus and Sales comps.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
45
out of 100
Analysts
25% buy
20 covering
1-year return
+33.0%
Dividend yield
4.40%

Dow Inc. Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Dow Inc. makes polyethylene, polyurethanes, silicones and other base and specialty plastics, mostly sold to packaging, construction and consumer goods makers, with a large footprint of integrated US Gulf Coast and European production. Its advantage is scale and feedstock integration in commodity petrochemicals, which tends to matter most when the cycle turns, though the current cycle is still weak for the sector. Trailing earnings are negative (ROE of -5.5%), so the valuation case rests on the forward multiple of 16.3x and on a revenue rebound of 19.7%, which would need to show up as margin recovery to be meaningful; the reported 9.8% gross margin and 11.6% operating margin leave little room for error. The stock's near-term fate depends on whether pricing and volumes in polyethylene improve, and on the pace of cost cuts already announced. At a $20.3B market cap with no index membership, the name is a cyclical turnaround candidate rather than a quality compounder, and the score of 45/100 reflects that. Worth a deeper look only if the team has a differentiated view on the petrochemical cycle.

AI-assisted·How I use AIWritten Oct 13, 2026
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
  • high
    Earnings collapse with negative margins
    EPS down 73.3% YoY; net margin -3.1% and ROE -5.2%. Company is unprofitable despite revenue growth, signalling operational distress or one-time charges.
  • high
    Elevated leverage amid earnings weakness
    Debt/Equity 1.12 is material. Combined with negative earnings and -11.1% five-year revenue CAGR, refinancing risk rises if conditions deteriorate further.
  • moderate
    Quality score collapse signals deterioration
    ACCE Quality subscore only 31/100. Recent +16 point score jump driven by valuation and growth, not operational improvement; underlying fundamentals remain weak.

AI research notes

AI-assisted·How I use AIWritten Oct 11, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Revenue surged 19.7% year over year, and earnings beat expectations by 15.2%, signaling strong near-term demand.
  • The stock trades at 16.5x forward earnings with a 4.9% dividend yield, offering income at a reasonable valuation.
  • Analysts see 18.3% upside to their mean price target of $33.63, with 26% rating the stock a buy.
Why it could disappoint
  • Five year revenue has fallen 11.1% annually, and the company is unprofitable with negative 3.1% net margins.
  • Return on equity of negative 5.5% and return on invested capital of negative 6.5% show the business destroys shareholder value.
  • Free cash flow yield of 1.2% is meager, and debt to equity of 1.12 leaves little room to protect a 4.9% dividend.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where DOW's valuation models land
Price
$32.61
Model fair valueConfidence: low
about $59.62
Model
Fair value
Upside
Analyst consensus
Sales comps
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bearish25% buy · 20 covering analysts
● Strong buy 4● Buy 1● Hold 13● Sell 2● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
+9.0%
1 month
+13.8%
3 months
+9.3%
6 months
-15.6%
YTD
+39.5%
1 year
+33.0%

SEC filings

Recent ACCE blog coverage

  • $DOW ACCE Score Drops 13 Points to 24 - What Drove It
    Dow Inc.'s ACCE composite score fell from 37 to 24. Here's what the subscore breakdown tells us about growth, quality, and value pressures.
    2026-06-24

Held by ETFs

ETFs we cover that hold Dow Inc. Common Stock among their largest holdings, by weight.

  • XLB · Materials Select Sector SPDR3.5% of the fund
  • RPV · Invesco S&P 500 Pure Value ETF2.0% of the fund
  • VAW · Vanguard Materials ETF1.4% of the fund
Holdings as of 2026-10-24

Recommendation history, last 12 months

DateTypeNewPreviousPrice
23 Oct 2026, 01:52 CESTACCE price target$33.00$27.00$31.81
4 Oct 2026, 00:00 CESTFair value$47.00$47.60$27.97
28 Sept 2026, 00:00 CESTFair value$47.60$49.19$28.02
25 Sept 2026, 00:00 CESTACCE price target$27.00first publication$28.65
25 Sept 2026, 00:00 CESTFair value$49.19$48.24$28.65
18 Sept 2026, 00:00 CESTFair value$48.24$49.62$30.08
14 Sept 2026, 00:00 CESTFair value$49.62$51.28$29.03
7 Sept 2026, 00:00 CESTFair value$51.28$52.28$29.44
2 Sept 2026, 00:00 CESTFair value$52.28$52.87$30.52
25 Aug 2026, 00:00 CESTFair value$52.87$54.14$31.50

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full DOW page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth52Value51Quality31Momentum45Total45
Valuation
Trailing P/E
no data
Forward P/E
18.2x
PEG
no data
P/B
1.30x
EV / Revenue
0.9x
Book value/sh
$21.96
Enterprise value
$36.4B
Profitability
ROE
-5.5%
FCF yield
-6.14%
ROIC
-6.0%
Health and risk
Debt / equity
1.22
Dividend yield
4.40%
Beta
0.41

Price

+31.4% · 1Y

Ask anything about DOW

Answered from Dow Inc. Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
ROEbetter than 17% of peers
low -6%-6%high 22%
Div yieldbetter than 100% of peers
low 0.5%4.4%high 4.4%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
DOW Dow Inc. Common Stock $32.61----5.5%3145
4004.T Resonac Holdings Corporation¥12820.00--44.4x8.1%5153
4091.T Nippon Sanso Holdings Corporation¥5425.00--16.9x12.1%6866
051910.KS LG ChemKRW 229000.00----5.7%3137
BAS.DE BASF€52.45€4226% above21.9x6.1%5168
4063.T Shin-Etsu Chemical¥5826.00¥892835% below23.0x11.2%7455
4021.T Nissan Chemical Corporation¥8122.00--22.8x21.8%8877

Sector report card

Where DOW ranks against its sector peers on each metric.

Computing percentiles…
  • PR Newswire•Oct 15, 2026
    Dow declares quarterly dividend of 35 cents per share
  • GlobeNewswire•Sep 16, 2026
    Univar Solutions Expands Homecare and Industrial Cleaning Portfolio with Dow Partnership in North America
  • PR Newswire•Sep 14, 2026
    Dow to participate in the 14th Annual Morgan Stanley Laguna Conference
6 more press releases · full archive on Investor+.INVESTOR
35 filings of 40
July 2026
Jul 24
10-QQuarterly reportPeriod 2026-06-30
View on SEC →
April 2026
Apr 24
10-QQuarterly reportPeriod 2026-03-31
View on SEC →
Apr 23
8-KCurrent reportPeriod 2026-04-23
View on SEC →
32 more filings + AI summaries on Investor+.INVESTOR